These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22637471)

  • 41. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
    Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
    van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
    Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of
    Kekenadze M; Rocca C; Turchetti V; Nagy S; Kvirkvelia N; Vashadze S; Kvaratskhelia E; Beridze M; Kaiyrzhanov R; Houlden H
    F1000Res; 2023; 12():1113. PubMed ID: 38464738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.
    Lindquist SG; Duno M; Batbayli M; Puschmann A; Braendgaard H; Mardosiene S; Svenstrup K; Pinborg LH; Vestergaard K; Hjermind LE; Stokholm J; Andersen BB; Johannsen P; Nielsen JE
    Clin Genet; 2013 Mar; 83(3):279-83. PubMed ID: 22650353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
    Glasmacher SA; Wong C; Pearson IE; Pal S
    JAMA Neurol; 2020 Mar; 77(3):367-376. PubMed ID: 31738367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.
    Niblock M; Smith BN; Lee YB; Sardone V; Topp S; Troakes C; Al-Sarraj S; Leblond CS; Dion PA; Rouleau GA; Shaw CE; Gallo JM
    Acta Neuropathol Commun; 2016 Feb; 4():18. PubMed ID: 26916632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. c9RAN translation: a potential therapeutic target for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia.
    Gendron TF; Cosio DM; Petrucelli L
    Expert Opin Ther Targets; 2013 Sep; 17(9):991-5. PubMed ID: 23844663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan.
    Tsai CP; Soong BW; Tu PH; Lin KP; Fuh JL; Tsai PC; Lu YC; Lee IH; Lee YC
    Neurobiol Aging; 2012 Sep; 33(9):2232.e11-2232.e18. PubMed ID: 22673113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C9orf72 repeat expansions are restricted to the ALS-FTD spectrum.
    Ticozzi N; Tiloca C; Calini D; Gagliardi S; Altieri A; Colombrita C; Cereda C; Ratti A; Pezzoli G; Borroni B; Goldwurm S; Padovani A; Silani V
    Neurobiol Aging; 2014 Apr; 35(4):936.e13-7. PubMed ID: 24169076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
    Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
    Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.
    Belzil VV; Bauer PO; Prudencio M; Gendron TF; Stetler CT; Yan IK; Pregent L; Daughrity L; Baker MC; Rademakers R; Boylan K; Patel TC; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):895-905. PubMed ID: 24166615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review.
    Schipper LJ; Raaphorst J; Aronica E; Baas F; de Haan R; de Visser M; Troost D
    Neuropathol Appl Neurobiol; 2016 Oct; 42(6):547-60. PubMed ID: 26373655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis.
    Herdewyn S; Zhao H; Moisse M; Race V; Matthijs G; Reumers J; Kusters B; Schelhaas HJ; van den Berg LH; Goris A; Robberecht W; Lambrechts D; Van Damme P
    Hum Mol Genet; 2012 Jun; 21(11):2412-9. PubMed ID: 22343411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pearls & Oy-sters: Familial Verbal Auditory Agnosia Due to
    Kim YS; Kim YE; Choung YH; Kim H; Kim HJ; Jung NY; Lee SM; Kim EJ; Moon SY
    Neurology; 2023 Nov; 101(20):e2046-e2050. PubMed ID: 37648532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
    Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
    J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.
    Watson A; Pribadi M; Chowdari K; Clifton S; Joel Wood ; Miller BL; Coppola G; Nimgaonkar V
    Psychiatry Res; 2016 Jan; 235():200-2. PubMed ID: 26723138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress.
    Zhang YJ; Jansen-West K; Xu YF; Gendron TF; Bieniek KF; Lin WL; Sasaguri H; Caulfield T; Hubbard J; Daughrity L; Chew J; Belzil VV; Prudencio M; Stankowski JN; Castanedes-Casey M; Whitelaw E; Ash PE; DeTure M; Rademakers R; Boylan KB; Dickson DW; Petrucelli L
    Acta Neuropathol; 2014 Oct; 128(4):505-24. PubMed ID: 25173361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of the FTD-ALS associated C9orf72 expansion in suicide victims.
    Solje E; Riipinen P; Helisalmi S; Särkioja T; Laitinen M; Hiltunen M; Hakko H; Remes AM
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):589-592. PubMed ID: 27388677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.